Effect of concurrent pathogen reduction (amotosalen/ UVA ) and gamma/x‐ray irradiation on biochemical characteristics of apheresis platelets in additive solution
Transfusion · 2025
DOI: 10.1111/trf.18085 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transfusion, 2025. Verfasst von M Reza Khoshi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Cellular Hematology, DBCD, OBRR, CBER, FDA, Silver Spring, Maryland, USA. Hauptthemen laut MEDLINE: Blood Platelets, Gamma Rays, Plateletpheresis, Ultraviolet Rays. Die Arbeit nennt 25 Literaturangaben. Gefördert von: FDA HHS, U.S. Food and Drug Administration.
Abstract (Originalsprache)
Background
Pathogen reduction (PR) may be used as an alternative to gamma or x‐ray irradiation (I) to prevent transfusion associated graft versus host disease (TA‐GVHD) if the pathogen reduction technology has been shown to inactivate residual lymphocytes. However, as I is considered the gold standard for reducing the risk of TA‐GVHD, some centers continue to perform I in addition to PR. This study investigated the effect of concurrent pathogen reduction and irradiation (PR/I) on the biochemical characteristics of apheresis platelets at day 1, 5, and 7 of storage at room temperature.
Methods
We compared in vitro characteristics of apheresis platelets (PLTs), PR PLTs, I PLTs, and PR/I PLTs at storage day 1, 5, and 7. PLTs from six healthy volunteers were suspended in 65% PAS‐3/35% plasma prior to splitting and treatment with PR, I, or PR/I. Parameters measured were: PLT loss, mean PLT volume (MPV), pH, glucose consumption, lactate production, CD62P, annexin V binding, PLT aggregation, mitochondrial membrane potential (MMP), and reactive oxygen species (ROS).
Results
PR/I PLTs did not show significant changes in measured parameters when compared to PR PLTs. However, when compared to control PLTs, PR and PR/I PLTs showed significant declines in PLT content, pH, MMP, aggregation and significant increases in MPV, CD62P, annexin V binding, and ROS production, mostly on day 7 of storage. Irradiation did not cause significant changes in measured parameters in comparison to control PLTs. Conclusions/Summary While PR impacts PLTs' biochemical characteristics and function, irradiation of PR PLTs did not cause additional significant changes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Cellular Hematology, DBCD, OBRR, CBER, FDA, Silver Spring, Maryland, USA.
- Department of Transfusion Medicine, NIH, Bethesda, Maryland, USA.
- OBRR, CBER, FDA, Silver Spring, Maryland, USA.
ORCID-Profile: M Reza Khoshi, Andrey Skripchenko
Förderung
- FDA HHS
- U.S. Food and Drug Administration
Zitieren
APA
Khoshi, M. R., Skripchenko, A., Seifu, R., Byrne, K., West-Mitchell, K., Conry-Cantilena, C., Villa, C. H., Simak, J., & Vostal, J. G. (2025). Effect of concurrent pathogen reduction (amotosalen/ UVA ) and gamma/x‐ray irradiation on biochemical characteristics of apheresis platelets in additive solution. Transfusion. https://doi.org/10.1111/trf.18085
Vancouver
Khoshi MR, Skripchenko A, Seifu R, Byrne K, West-Mitchell K, Conry-Cantilena C, et al. Effect of concurrent pathogen reduction (amotosalen/ UVA ) and gamma/x‐ray irradiation on biochemical characteristics of apheresis platelets in additive solution. Transfusion. 2025. doi:10.1111/trf.18085
BibTeX
@article{Khoshi2025,
author = {Khoshi, M Reza and Skripchenko, Andrey and Seifu, Robel and Byrne, Karen and West-Mitchell, K and Conry-Cantilena, Cathy and Villa, Carlos H and Simak, Jan and Vostal, Jaroslav G},
title = {Effect of concurrent pathogen reduction (amotosalen/ UVA ) and gamma/x‐ray irradiation on biochemical characteristics of apheresis platelets in additive solution},
journal = {Transfusion},
year = {2025},
doi = {10.1111/trf.18085}
}
EUVIMED